Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human CARD11 Antikörper:
anti-Mouse (Murine) CARD11 Antikörper:
anti-Rat (Rattus) CARD11 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal CARD11 Primary Antibody für IHC, ELISA - ABIN1030313
Cheng, Hamilton, Kane: Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production. in Molecular immunology 2014
Show all 2 Pubmed References
Human Polyclonal CARD11 Primary Antibody für IHC (p), IHC - ABIN249816
Rajasekaran, Kumar, Schuldt, Peterson, Vanhaesebroeck, Dixit, Thakar, Malarkannan: Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells. in Nature immunology 2013
Show all 2 Pubmed References
CARMA1 may be aberrantly upregulated in T-ALL, leading to disease progression and migration of leukemic cells to the CNS
findings indicate that a single hypomorphic mutation in CARD11 can cause potentially correctable cellular defects that lead to atopic dermatitis
NF-kappaB (zeige NFKB1 Antikörper) and beta-catenin (zeige CTNNB1 Antikörper) signaling by gain-of-function mutations in CARMA1 augments WNT (zeige WNT2 Antikörper) stimulation and is required for regulating the expression of distinct NF-kappaB (zeige NFKB1 Antikörper) target genes to trigger cell-intrinsic and extrinsic processes that promote DLBCL lymphomagenesis
CARD11 mutations are rare in patients with CD5 (zeige CD5 Antikörper)+ DLBCL.
results define molecular determinants that control the production of Lin(Ub)n-Bcl10 (zeige BCL10 Antikörper), an important signaling intermediate in TCR and oncogenic CARD11 signaling.
We evaluated the relationship between rs4722404 polymorphism in the CARD11 gene, and the risk and clinical features of psoriasis vulgaris in a southern Chinese Han cohort.We identified no association between the SNP and risk of psoriasis vulgaris.
single amino acid oncogenic CARD11 mutations can perturb or bypass the action of redundant inhibitory REs to achieve the level of hyperactive CARD11 signaling required to support lymphoma growth.
Cooperative Control of Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling by an Unusual Array of Redundant Repressive Elements.
CARMA1- and MyD88 (zeige MYD88 Antikörper)-dependent activation of Jun (zeige JUN Antikörper)/ATF-type AP-1 (zeige FOSB Antikörper) complexes is a hallmark of ABC (zeige ABCB6 Antikörper) diffuse large B-cell lymphomas.
Data show that caspase recruitment domain-containing protein 11/B-cell CLL/lymphoma 10 (zeige BCL10 Antikörper)/mucosa-associated lymphoid tissue lymphoma translocation gene 1 (zeige MALT1 Antikörper) signaling drives lymphoproliferation (zeige FAS Antikörper) through NF-kappa B (zeige NFKB1 Antikörper) and c-Jun N-terminal kinase activation.
synergistic activity of Card11 mutant and Bcl6 (zeige BCL6 Antikörper) in the development of diffuse large B-cell lymphoma in a mouse model
CARMA1 clustering through SH3-GUK domain interactions is required for its activation of NF-kappaB (zeige NFKB1 Antikörper) signalling
data suggest that Carma1 and MALT1 play previously unappreciated roles in the activation of mTOR signaling in T cells after engagement of the TCR.
CARMA1 CARD shows the first homo-dimeric structure of CARD formed by a disulfide bond and reveals a possible biologically important homo-dimerization mechanism
Data indicate that caspase recruitment domain-containing protein 11 (CARD11) is involved in the pathogenesis of collagen-induced arthritis (CIA (zeige NCOA5 Antikörper)) by formation of the CARD11/Bcl10 (zeige BCL10 Antikörper) complex and enhancement of the Th17 cell response.
Genetic approach demonstrates a critical role for the CARD function of CARMA1 in Treg cell development in vivo.
both CARMA1 CARD and BCL10 CARD easily self-oligomerized under physiological conditions.
Findings show that regulation of CARD11 signaling is a critical switch governing the decision between death and proliferation in antigen-stimulated mature B cells.
TCR/CARMA1/NF-kappaB (zeige NFKB1 Antikörper) controls completion of Th17 differentiation.
These studies provide molecular insight into the assembly of CARMA1 and BCL10.
The protein encoded by this gene belongs to the membrane-associated guanylate kinase (MAGUK) family, a class of proteins that functions as molecular scaffolds for the assembly of multiprotein complexes at specialized regions of the plasma membrane. This protein is also a member of the CARD protein family, which is defined by carrying a characteristic caspase-associated recruitment domain (CARD). This protein has a domain structure similar to that of CARD14 protein. The CARD domains of both proteins have been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. When expressed in cells, this protein activated NF-kappaB and induced the phosphorylation of BCL10.
CARD-containing MAGUK protein 1
, bcl10-interacting maguk protein 3
, carma 1
, caspase recruitment domain-containing protein 11
, caspase recruitment domain family, member 11
, caspase recruitment domain-containing protein 11-like